Literature DB >> 28878847

Potential Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer.

Ihn-Ho Cho1, Eun-Jung Kong1.   

Abstract

The whole-body positron emission tomography (PET)/magnetic resonance (MR) scan is a cutting edge technology providing comprehensive structural information from MR imaging and functional features from PET in a single session. Recent research findings and clinical experience have shown that 18F-fluorodeoxyglucose (FDG) whole-body PET/MR imaging has a diagnostic performance comparable with or superior to that of PET/CT in the field of oncology, including for breast cancer. In particular, FDG PET/MR mammography in the prone position with the breast hanging in a pendant manner can provide more comprehensive information about the metabolism, anatomy, and functional features of a breast lesion than a whole-body PET/MR scan. This article reports on current state-of-the-art PET/MR mammography in patients with breast cancer and the prospects for potential application in the future.

Entities:  

Keywords:  Attenuation correction; Breast cancer; FDG; Lymphatic metastasis; PET/MR; Staging

Year:  2016        PMID： 28878847      PMCID： PMC5567616          DOI： 10.1007/s13139-016-0446-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


  70 in total

Review 1.  Problem solving MR imaging of the breast.

Authors:  Carol H Lee
Journal:  Radiol Clin North Am       Date:  2004-09       Impact factor: 2.303

2.  Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.

Authors:  Wendie A Berg; Kathleen S Madsen; Kathy Schilling; Marie Tartar; Etta D Pisano; Linda Hovanessian Larsen; Deepa Narayanan; Al Ozonoff; Joel P Miller; Judith E Kalinyak
Journal:  Radiology       Date:  2010-11-12       Impact factor: 11.105

Review 3.  Diffusion-weighted magnetic resonance imaging and its application to cancer.

Authors:  Elizabeth M Charles-Edwards; Nandita M deSouza
Journal:  Cancer Imaging       Date:  2006-09-13       Impact factor: 3.909

4.  Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.

Authors:  Leonardo Pace; Emanuele Nicolai; Angelo Luongo; Marco Aiello; Onofrio A Catalano; Andrea Soricelli; Marco Salvatore
Journal:  Eur J Radiol       Date:  2013-11-23       Impact factor: 3.528

Review 5.  Evolving role of positron emission tomography in breast cancer imaging.

Authors:  William B Eubank; David A Mankoff
Journal:  Semin Nucl Med       Date:  2005-04       Impact factor: 4.446

6.  Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel (1)H-magnetic resonance spectroscopy and (18)F-fluorodeoxyglucose positron emission tomography.

Authors:  Nariya Cho; Seock-Ah Im; Keon Wook Kang; In-Ae Park; In Chan Song; Kyung-Hun Lee; Tae-Yong Kim; Hyunjong Lee; In Kook Chun; Hai-Jeon Yoon; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2015-09-17       Impact factor: 5.315

7.  Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.

Authors:  Bas B Koolen; Renato A Valdés Olmos; Paula H M Elkhuizen; Wouter V Vogel; Marie-Jeanne T F D Vrancken Peeters; Sjoerd Rodenhuis; Emiel J Th Rutgers
Journal:  Breast Cancer Res Treat       Date:  2012-07-28       Impact factor: 4.872

Review 8.  Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications.

Authors:  Wendy DeMartini; Constance Lehman; Savannah Partridge
Journal:  Acad Radiol       Date:  2008-04       Impact factor: 3.173

9.  Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.

Authors:  Sung Hun Kim; Eun Suk Cha; Hyeon Sook Kim; Bong Joo Kang; Jae Jeong Choi; Ji Han Jung; Yong Gyu Park; Young Jin Suh
Journal:  J Magn Reson Imaging       Date:  2009-09       Impact factor: 4.813

Review 10.  ¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.

Authors:  Stefanie Avril; Raymond F Muzic; Donna Plecha; Bryan J Traughber; Shaveta Vinayak; Norbert Avril
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057
View more
  4 in total

1.  What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?

Authors:  Diomidis Botsikas; Ilias Bagetakos; Marlise Picarra; Ana Carolina Da Cunha Afonso Barisits; Sana Boudabbous; Xavier Montet; Giang Thanh Lam; Ismini Mainta; Anastasia Kalovidouri; Minerva Becker
Journal:  Eur Radiol       Date:  2018-09-28       Impact factor: 5.315

2.  What is the Diagnostic Performance of 18F-FDG-PET/MRI in the Detection of Bone Metastasis in Patients with Breast Cancer?

Authors:  Filiz Çelebi
Journal:  Eur J Breast Health       Date:  2019-10-01

3.  Investigation of Added Value of Imaging Performed in a Prone Position to Standard 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Staging in Patients with Breast Cancer.

Authors:  Ezgi Başak Erdoğan; Mehmet Aydın
Journal:  Mol Imaging Radionucl Ther       Date:  2022-02-02

4.  [89Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models.

Authors:  Yun Lu; Meng Li; Adriana V F Massicano; Patrick N Song; Ameer Mansur; Katherine A Heinzman; Benjamin M Larimer; Suzanne E Lapi; Anna G Sorace
Journal:  Molecules       Date:  2021-03-12       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.